«Combination of structure- and ligand-based AI methods for molecular design for future medicinal chemistry DMT platform»
Automated molecular design is a central component of future closed-loop DMT platforms for medicinal chemistry applications. Two projects towards such automated design concepts will be presented combining information on target structure and ligand activities from iterative DMT cycles.
Markus Lill, University of Basel
Professor for Computational Pharmacy at the Department of Pharmaceutical Sciences